Intellia Therapeutics, Inc. (NTLA) · Peers
Intellia Therapeutics against the 15 other companies here in its SEC industry, In Vitro & In Vivo Diagnostic Substances. Each figure is the one on the company's own page; the median is the peers', and the rank is among all 16, highest first.
Measure by measure
| Measure | NTLA | Peer median | Rank |
|---|---|---|---|
| Market value | $1.68B | median $170.10M | 5 of 16 |
| P/S | 28.2× | median 4.2× | 4 of 16 |
| FCF yield | -20.8% | median -7.2% | 9 of 15 |
| Operating margin | -711.7% | median -12.2% | 11 of 12 |
| Net margin | -672.2% | median -14.0% | 11 of 12 |
| ROIC | -115.4% | median -7.2% | 10 of 11 |
| ROE | -55.0% | median -26.8% | 9 of 12 |
| Revenue growth (4y, yearly) | 19.6% | median 8.7% | 4 of 15 |
| Current ratio | 6.6× | median 2.9× | 4 of 15 |
| Stock pay / revenue | 114.1% | median 4.3% | 3 of 15 |
| Share count change | 9.6% | median 6.2% | 7 of 15 |
Green where Intellia Therapeutics is on the better side of the median, red where on the worse; no colour where higher is neither, like size or dividend yield.
The peers, largest first
| Company | Market value | P/E | ROIC | Score |
|---|---|---|---|---|
| NTLAIntellia Therapeutics, Inc. | $1.68B | P/E – | -115.4% | 3.8 |
| IDXXIDEXX Laboratories Inc | $43.79B | P/E 38.4× | 57.2% | 6.8 |
| LNTHLantheus Holdings, Inc. | $6.55B | P/E 23.8× | 18.5% | 7.7 |
| NEOGNeogen Corp | $2.57B | P/E – | -0.6% | 4.4 |
| CLDXCelldex Therapeutics, Inc. | $2.33B | P/E – | – | 2.7 |
| QDELQuidelOrtho Corp | $986.11M | P/E – | -13.8% | 3.0 |
| MYGNMyriad Genetics Inc | $553.81M | P/E – | -25.2% | 5.3 |
| TKNOAlpha Teknova, Inc. | $365.08M | P/E – | -21.4% | 4.4 |
| NNNNAnbio Biotechnology | $170.10M | P/E 26.6× | 25.0% | 6.6 |
| ICCCImmucell Corp | $95.45M | P/E 25.3× | 9.8% | 7.3 |
| IMDXInsight Molecular Diagnostics Inc. | $94.57M | P/E – | – | 3.4 |
| AWHLAspira Women's Health Inc. | $10.26M | P/E – | – | 4.5 |
| BMRABiomerica Inc | $5.44M | P/E – | -213.5% | 3.2 |
| CDIOCardio Diagnostics Holdings, Inc. | $4.85M | P/E – | -68.7% | 3.7 |
| QCLSQ/C Technologies, Inc. | $4.09M | P/E – | – | 8.0 |
| VNRXVolitionrx Ltd | $2.37M | P/E – | – | 4.1 |
The industry is the Standard Industrial Classification code the company registered with the SEC. It is a broad label: a peer group is a starting point for comparing, not proof that two businesses are alike. None of this is advice.